Umbrex is pleased to welcome Brenna Rauw with Vulpine Strategies. Brendan Rauw was a project leader at BCG in the private equity and healthcare practices, and spent ten years after BCG leading technology commercialization for universities. Brendan has particular expertise in intellectual property, licensing, and entrepreneurship in the life sciences.
Brendan lives in Portland, OR, advising private equity investors and pre-revenue life science companies across the country on strategy, partnering, and market assessment. Brendan is particularly interested in healthcare and life sciences projects relating to market analysis and due diligence.